Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.28 in the prior trading day, Eliem Therapeutics Inc (NASDAQ: ELYM) closed at $8.43, up 1.81%. In other words, the price has increased by $1.81 from its previous closing price. On the day, 4.59 million shares were traded. ELYM stock price reached its highest trading level at $8.57 during the session, while it also had its lowest trading level at $7.94.
Ratios:
Our goal is to gain a better understanding of ELYM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9421.93. For the most recent quarter (mrq), Quick Ratio is recorded 60.41 and its Current Ratio is at 60.41. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’24 when Pimblett Emily sold 1,191 shares for $8.18 per share. The transaction valued at 9,741 led to the insider holds 7,564 shares of the business.
Morisset Valerie sold 69,005 shares of ELYM for $554,170 on Jul 22 ’24. The EVP, R&D AND CSO now owns 31,317 shares after completing the transaction at $8.03 per share. On Jul 19 ’24, another insider, Morisset Valerie, who serves as the EVP, R&D AND CSO of the company, sold 60,201 shares for $7.21 each. As a result, the insider received 434,325 and left with 100,322 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELYM now has a Market Capitalization of 565317504 and an Enterprise Value of 342277184.
Stock Price History:
Over the past 52 weeks, ELYM has reached a high of $11.55, while it has fallen to a 52-week low of $2.35. The 50-Day Moving Average of the stock is 16.54%, while the 200-Day Moving Average is calculated to be 61.14%.
Shares Statistics:
The stock has traded on average 267.75K shares per day over the past 3-months and 765960 shares per day over the last 10 days, according to various share statistics. A total of 67.06M shares are outstanding, with a floating share count of 51.90M. Insiders hold about 22.60% of the company’s shares, while institutions hold 65.15% stake in the company. Shares short for ELYM as of 1724976000 were 1133526 with a Short Ratio of 4.23, compared to 1722384000 on 994932. Therefore, it implies a Short% of Shares Outstanding of 1133526 and a Short% of Float of 2.34.
